The 2026 SM:ART Trial is fully subscribed

Every place in the 2026 cohort has been allocated. The next cohort is planned for Spring 2027 and is expected to be open to a wider range of reinforced-concrete structures. Register interest below and Structivate will contact you when applications open.

Register interest in the Spring 2027 cohort

Where the structure, or your asset portfolio, is based.

The next cohort is expected to consider a wider range of reinforced-concrete structures.

Structure type, age, known corrosion concerns, and the decision you are working towards. Up to 300 characters.

Details submitted via this form are used only to contact you about the next SM:ART Trial cohort. See the Privacy Notice for details.

Frequently asked

  • Is the current SM:ART Trial cohort full?

    Yes. Every place in the 2026 SM:ART Trial has been allocated. That cohort was limited to reinforced-concrete bridges with half-joints.

  • When does the next cohort open?

    Structivate is planning the next cohort for Spring 2027. Organisations that have registered interest will be contacted when the date, scope and terms are confirmed and applications open.

  • What structures will the next cohort consider?

    The next cohort is expected to be open to a wider range of reinforced-concrete structures, not only bridges with half-joints. Ageing reinforced-concrete assets where corrosion uncertainty is holding up a repair, replacement or life-extension decision are the intended fit. Scope will be confirmed when applications open.

  • What does The SM:ART Trial include?

    In the 2026 cohort, selected partners receive a candidate-structure scoping call, site visit and deployment plan, sensor installation, a three-month monitoring period, an engineer-grade asset intelligence report setting out what was measured and how it is interpreted, and a commercial review point with a continuation pathway. Decisions on any intervention stay with the asset owner and their engineering consultant. The framework for the next cohort will be confirmed when applications open.

  • Is there a cost?

    In the 2026 cohort: Sensors and analytics are provided at no cost under Enterprise Ireland Commercialisation Fund support through April 2027. Asset owners pay for installation and traffic management. That arrangement applies to the 2026 cohort only. Commercial terms for the Spring 2027 cohort will be confirmed when applications open.

  • What does registering interest involve?

    A short form: your name, organisation, role, region, the type of structure, and a few lines about the structure or portfolio you have in mind. Registering interest does not guarantee a place. Structivate will review registrations against the next cohort's scope once it is confirmed and contact suitable organisations first.

  • What do trial partners commit to?

    Sharing existing inspection reports, drawings, and known defects (where available); coordinating site access and safety; assigning a technical owner; supporting installation logistics; attending review meetings; allowing anonymised case study use (subject to approval); and agreeing a commercial review point post-trial.

  • What is SM:ART?

    SM:ART is a corrosion-monitoring system developed at TU Dublin with Enterprise Ireland Commercialisation Fund support. Structivate is being established to bring SM:ART to market, and operates the SM:ART Trials.

Technological University Dublin
Enterprise Ireland

SM:ART is being actively developed at TU Dublin with Enterprise Ireland Commercialisation Fund support.